Your browser doesn't support javascript.
loading
From an understanding of etiopathogenesis to novel therapies-what is new in the treatment of celiac disease?
Skoracka, Kinga; Hryhorowicz, Szymon; Tovoli, Francesco; Raiteri, Alberto; Rychter, Anna Maria; Slomski, Ryszard; Dobrowolska, Agnieszka; Granito, Alessandro; Krela-Kazmierczak, Iwona.
Affiliation
  • Skoracka K; Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
  • Hryhorowicz S; Doctoral School, Poznan University of Medical Sciences, Poznan, Poland.
  • Tovoli F; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
  • Raiteri A; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Rychter AM; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Slomski R; Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
  • Dobrowolska A; Laboratory of Nutrigenetics, Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
  • Granito A; Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
  • Krela-Kazmierczak I; Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.
Front Pharmacol ; 15: 1378172, 2024.
Article in En | MEDLINE | ID: mdl-38698821
ABSTRACT
Celiac disease, a chronic autoimmune disorder caused by genetic factors and exposure to gluten, is increasingly being recognized and diagnosed in both children and adults. Scientists have been searching for a cure for this disease for many years, but despite the impressive development of knowledge in this field, a gluten-free diet remains the only recommended therapy for all patients. At the same time, the increasing diagnosis of celiac disease in adults, which was considered a childhood disease in the 20th century, has opened a discussion on the etiopathology of the disease, which is proven to be very complex and involves genetic, immunological, nutritional, environmental and gut microbiota-related factors. In this review, we extensively discuss these factors and summarize the knowledge of the proposed state-of-the-art treatments for celiac disease to address the question of whether a better understanding of the etiopathogenesis of celiac disease has opened new directions for therapy.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2024 Type: Article Affiliation country: Poland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2024 Type: Article Affiliation country: Poland